跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 121 条关于
“RSVPreF3-AS01E”
全部
121
临床试验
95
药物
11
机构
0
资讯
15
去年
RSV Vaccines Show Weaker Immune Response in Immunocompromised Older Adults
去年
GSK's Arexvy Receives Expanded Approval in Japan for RSV Prevention in Adults Aged 50-59
2个月前
GSK's M72/AS01E Tuberculosis Vaccine Candidate Advances Toward Global Access with Serum Institute of India Manufacturing Agreement
去年
Phase 3 Trial of M72/AS01E TB Vaccine Underway in Malawi
去年
RSV Therapeutic Pipeline Shows Promise with Novel Therapies and Clinical Advancements
9个月前
EMA Committee Recommends Expanding GSK's RSV Vaccine to All Adults 18 and Over
2年前
Three RSV Vaccines Now Available for Older Adults as FDA Approves Moderna's mRESVIA
去年
Late-Stage Trials Offer Hope in the Fight Against Tuberculosis with Novel Vaccine Candidates
3年前
Clover Biopharmaceuticals Advances RSV Vaccine SCB-1019 with U.S. IND Clearance for Revaccination Study
去年
GSK and ViiV Healthcare Showcase Infectious Disease Advances at IDWeek 2024
第 1 页,共 2 页
上一页
下一页